Tony Loebel, M.D. (@TonyLoebel) header
Tony Loebel, M.D. (@TonyLoebel) profile picture

Tony Loebel, M.D.

@TonyLoebel

Innovative Pharmaceutical Chief Executive, former President & CEO of Sunovion. Likes & RTs are not endorsements.

 New York, USA
Joined May 2013
  • Tweets13
  • Following137
  • Followers66
2Media
Photo by Tony Loebel, M.D. (@TonyLoebel)Photo by Tony Loebel, M.D. (@TonyLoebel)
Congratulations to our @Sunovion team on achieving this clinical development milestone. We are committed to advancing ulotaront for the potential treatment of generalized anxiety disorder and other serious #mentalhealth conditions.
This Post is from an account that no longer exists. Learn more
1
1
10
906
Thank you, Jannie, for sharing your thoughtful voice and experiences on #WomensEqualityDay. Sunovion is committed to an equitable workplace, the development of talent and advancement of women. We thank our Women Rising colleagues for their impactful leadership and contributions.
This Post is from an account that no longer exists. Learn more
2
This #PrideMonth and all year-round, we support our Pride Alliance Business Impact Group and embrace a welcoming, supportive and collaborative work environment for LGBTQ+ employees. We value the dignity and humanity of our teammates as well as the patients and customers we serve.
This Post is from an account that no longer exists. Learn more
2
People living with Parkinson’s disease clearly need improved therapies in this area of significant unmet medical need. Sunovion is proud to be engaged in the research and advancement of new treatments to help improve the lives of people suffering with #Parkinsons disease.
This Post is from an account that no longer exists. Learn more
3
We’re proud to have initiated the Phase 3 program evaluating non-racemic amisulpride for people with bipolar depression. This important milestone reflects the ongoing commitment at Sunovion to innovation in #CNS drug development that can transform the lives of patients.
This Post is from an account that no longer exists. Learn more
5
Your retweet can make the difference for someone affected by Parkinson's disease! Make sure people know that they can follow our page to start living better with PD. You never know who you can help us reach 💙
27
762
24
654
I look forward to sharing the stage at #CNSSummit2021 with industry peers to discuss #neuroscience innovation and other important clinical development issues. Together, we can advance new treatments for the patients we serve.
Image from Tony Loebel, M.D. (@TonyLoebel)
3
1
13
Thanks Team Sunovion for your care, commitment and efforts to #BeatParkinsons @NeParkinsons
This Post is from an account that no longer exists. Learn more
3
(1/2) We're proud to collaborate with @OtsukaUS on a shared mission to address the enormous unmet needs of people living with serious neuropsychiatric conditions. This collaboration reinforces our innovative discovery & development work and our neuropsychiatry capabilities.
This Post is from an account that no longer exists. Learn more
1
2
(2/2) Together, with Sumitomo Dainippon Pharma, we expect to rapidly advance our novel compounds that show promise in offering new treatments for brain disorders. We look forward to this purpose-driven collaboration which can help improve the lives of patients around the world.
2
Looking forward to the @PharmaVOICE 100 Red Jacket Panel to discuss how @Sunovion and peers can continue to spark innovation and ignite change in the #lifesciences industry for patients. #PV100
Image from Tony Loebel, M.D. (@TonyLoebel)
1
1
3
We’re pleased to share @Sunovion's new website that reflects our pressing work today and commitment to a brighter future for patients living with brain disorders. Learn about our team’s patient-inspired purpose and #CNS science-driven innovation.
This Post is from an account that no longer exists. Learn more
2
Thank you @AMSACS and Team @Sunovion for inspiring and advancing the next generation of #CNS innovation. #STEM
This Post is from an account that no longer exists. Learn more
1
1
6
Load more